Tag: Power of Pain Foundation
-
Share Your Story; Jan Marie Moore
After 15 years of suffering (docs cut a nerve in my c-spine during neck surgery), I have been diagnosed with CRPS. My spine is on fire 247. My body has atrophied terribly. I can barely walk or use my arms. Doc put me on Nucynta and a muscle relaxer. Its only helping a little. I’m…
-
The Pain Experience: Meeting the Needs of Pain Patients by Stephanie Lynn Christianson
The Pain Experience: Meeting the Needs of Pain Patients by Stephanie Lynn Christianson Executive Summary Pain is difficult to define with certainty. Healthcare professionals are confronted with a high degree of complexity which affect the standards of care. The International Association for the Study of Pain (IASP) defines pain as, “An unpleasant sensory and emotional…
-
Michigan Pain Survivor—Learning a New “Normal” By Karen Shay
Michigan Pain Survivor—Learning a New “Normal” By Karen Shay Editor’s Note: Karen Shay spent 23 years practicing in Occupational Therapy as a treating therapist with patients with multiple types of disorders and diagnoses, as well as a manager. After two cervical spine surgeries and one lumbar surgery, resulting in nerve damage adding to the already…
-
BE THE GIFT OF HOPE – BE A HERO
BE THE GIFT OF HOPE – BE A HERO By Barby Ingle In January my last living grandparent passed away. Now, my father has failing kidneys and is on dialysis. For the past two years he has been in desperate need of a kidney transplant. A little over a month ago, I lost my mother…
-
NEW Investigational drug being studied in participants with high cholesterol or other risk factors for heart disease
The SPIRE program is looking for people who are taking a cholesterol lowering medication but still have high cholesterol. If you qualify, you might be interested in participating in a research study. This study evaluates the PCSK9 inhibitor, Bococizumab compared to placebo, in reducing the occurrence of major cardiovascular events, including cardiovascular death, myocardial infarction,…
-
MOVANTIK™ (naloxegol) tablets for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain launched in the US
MOVANTIK™ (naloxegol) tablets for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain launched in the US Tuesday, 31 March 2015 AstraZeneca (NYSE: AZN) announced today that MOVANTIK™ (naloxegol) has launched in the United States. On September 16, 2014, the US Food and Drug Administration (FDA) approved MOVANTIK as the first once-daily…